Abstract:We have demonstrated that stromal cell-derived factor 1(SDF-1) protects against palmitate-induced cardiac cell death via CXCR7-mediated activation of AMPK signaling (Diabetes 62:2545-2558, 2013). Whether SDF-1 prevents diabetic cardiomyopathy (DCM) and what the underlying mechanism has not been addressed. Here we evaluated the prevention of SDF-1 from DCM in a high fat diet plus streptozotocin (HFD/STZ)-induced type 2 diabetic model in C57BL/6J mice. After 1 month on HFD, the HFD-fed mice were injected with one low dose STZ (100mg/kg body weight, ip). Five days after STZ injection, mice with blood glucose levels ≥250 mg/dl were defined as diabetic. In parallel, the age-matched normal diet-fed mice injected with a same volume of vehicle were used as control. After onset of diabetes, the mice were maintained on HFD or normal diet for another 4 months with or without SDF-1 treatment. Then cardiac function was assayed again, and the mice were sacrificed and cardiac tissue collected for cardiomyopathic index assay. We found that 1 month HFD feeding induced a significant insulin resistance without effect on cardiac function, but continued HFD feeding after STZ injection significantly increased insulin resistance and blood glucose, as well as blood insulin, triglyceride and cholesterol levels. Furthermore, HFD/STZT significantly impaired cardiac function, which were accompanied by increased cardiac inflammation, oxidative stress and fibrotic remodeling. Treatment with SDF-1 dose-dependently prevented diabetes-induced cardiac dysfunction, inflammation and remodeling, but without significant effects on the above mentioned other pathophysiological changes. Mechanistic study demonstrated that diabetes significantly inhibited the function of AMPK and Nrf2, and the expression of CXCR7, but not CXCR4; while treatment with SDF-1 significantly preserved AMPK and Nrf2 function and CXCR7 expression. Knockout CXCR4 did not affect SDF-1 preservation of AMPK and Nrf2 function, but SiRNA knockdown of AMPK resulted in blockade of SDF-1 preservation of Nrf2 function. These results indicate that SDF-1 prevents from DCM via CXCR7/AMPK-mediated Nrf2 activation in type 2 diabetic mice.

Sulforaphane Prevents the Development of Cardiomyopathy in Type 2 Diabetic Mice Probably by Reversing Oxidative Stress-Induced Inhibition of LKB1/AMPK Pathway.

Protective Effects of Sulforaphane on Type 2 Diabetes-Induced Cardiomyopathy Via AMPK-mediated Activation of Lipid Metabolic Pathways and NRF2 Function.

Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation

Sulforaphane prevents type 2 diabetes-induced nephropathy via AMPK-mediated activation of lipid metabolic pathways and Nrf2 antioxidative function

GW25-e2307 Sulforaphane Prevents Type 2 Diabetes Induced Cardiomyopathy Probably by Up-Regulation of AMPK Expression

Sulforaphane Prevention of Diabetes-Induced Aortic Damage Was Associated with the Up-Regulation of Nrf2 and Its Down-Stream Antioxidants

Metallothionein Is Downstream Of Nrf2 And Partially Mediates Sulforaphane Prevention Of Diabetic Cardiomyopathy

Sulforaphane Ameliorates High-Fat-Diet-Induced Metabolic Abnormalities in Young and Middle-Aged Obese Male Mice

Sulforaphane Attenuation of Type 2 Diabetes-Induced Aortic Damage Was Associated with the Upregulation of Nrf2 Expression and Function

Prevention of diabetic nephropathy by sulforaphane: possible role of Nrf2 upregulation and activation.

The Protective Effect of Sulforaphane on Type II Diabetes Induced by High-Fat Diet and Low-Dosage Streptozotocin.

Sulforaphane Inhibits Foam Cell Formation and Atherosclerosis via Mechanisms Involving the Modulation of Macrophage Cholesterol Transport and the Related Phenotype

Protection against diabetic cardiomyopathy is achieved using a combination of sulforaphane and zinc in type 1 diabetic OVE26 mice.

GW26-e4479 Nrf2 is Crucially Required for Sulforaphane to Prevent High Fat Diet/Low Dose STZ Induced Diabetic Cardiomyopathy

Broccoli sprout extract prevents diabetic cardiomyopathy via Nrf2 activation in db/db T2DM mice

Protection by sulforaphane from type 1 diabetes-induced testicular apoptosis is associated with the up-regulation of Nrf2 expression and function.

Abstract 279: Stromal Cell-derived Factor-1 Prevents from Diabetic Cardiomyopathy Via Cxcr7/ampk-mediated Nrf2 Activation in Type 2 Diabetic Mice

Sulforaphane Reduction of Testicular Apoptotic Cell Death in Diabetic Mice is Associated with the Upregulation of Nrf2 Expression and Function.

Sulforaphane Attenuation of Experimental Diabetic Nephropathy Involves GSK-3 Beta/fyn/nrf2 Signaling Pathway

Sulforaphane Protects Against Cardiovascular Disease Via Nrf2 Activation.

Protective effects of sulforaphane on diabetic retinopathy: activation of the Nrf2 pathway and inhibition of NLRP3 inflammasome formation